{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[11,2,11,3],[12,2,12,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910457116103321"]
[null,null,"Titolo",null,"WHO model formulary 2008 [[electronic resource] /] / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill]"]
[null,null,"Pubbl/distr/stampa",null,"Geneva, : World Health Organization, 2009"]
[null,null,"ISBN",null,"1-282-45614-8"]
[{"$nulls":4},"9786612456145"]
[{"$nulls":4},"92-4-068424-7"]
[null,null,"Descrizione fisica",null,"1 online resource (645 p.)"]
[null,null,"Disciplina",null,"615.13"]
[null,null,"Soggetti",null,"Medicine"]
[{"$nulls":4},"Drugs - Prescribing"]
[{"$nulls":4},"Electronic books."]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Based on the 15th Model list of essential medicines 2007.\""]
[{"$nulls":4},"Includes index."]
[null,null,"Nota di contenuto",null,"WHO MODEL FORMULARY 2008; Title Page; Contents; Abbreviations; Introduction; Changes to the WHO Model List of Essential; General advice to prescribers; 1. Anaesthetics; 2. Analgesics, antipyretics, non-steroidal anti-inflammatory; 3. Antiallergics and medicines used in anaphylaxis; 4. Antidotes and other substances used in poisonings; 5. Anticonvulsants/antiepileptics; 6. Anti-infective medicines; 7. Antimigraine medicines; 8. Antineoplastic, immunosuppressives and medicines used; 9. Antiparkinsonism medicines; 10. Medicines affecting the blood; 11. Blood products and plasma substitutes"]
[{"$nulls":4},"12. Cardiovascular medicines13. Dermatological medicines (topical); 14. Diagnostic agents; 15. Disinfectants and antiseptics; 16. Diuretics; 17. Gastrointestinal medicines; 18. Hormones, other endocrine medicines and contraceptives; 19. Immunologicals; 20. Muscle relaxants (peripherally-acting) and cholinesterase; 21. Ophthalmological preparations; 22. Oxytocics and antioxytocics; 23. Peritoneal dialysis solution; 24. Psychotherapeutic medicines; 25. Medicines acting on the respiratory tract; 26. Solutions correcting water, electrolyte and acid-base; 27. Vitamins and minerals"]
[{"$nulls":4},"Appendix 1: InteractionsAppendix 2: Pregnancy; Appendix 3: Breastfeeding; Appendix 4: Renal impairment; Appendix 5: Hepatic impairment; Index"]
[null,null,null,"Sommario/riassunto","Since its first publication in 2002, the WHO Model Formulary has become an indispensable source of independent information on essential medicines for pharmaceutical policy-makers and prescribers worldwide. The Model Formulary is the authoritative guide on how to make effective use of the medicines on the WHO Model List of Essential Medicines, so improving patient safety, and limiting unnecessary medical spending. For each medicine the Model Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine fo"]